PROTOCOL NIDA-CTN-0046-A-1


Site Influences on Treatment Effects - Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant-Dependent Outcome

Dennis McCarty, PhD
Lead Investigator
Professor, Department of Public Health and Preventive Medicine
Oregon Health & Science University
mccartyd@ohsu.edu

This ancillary study is related to CTN-0046, "Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence"

Site variations in study outcomes are apparent in clinical trials conducted within the National Drug Abuse Treatment Clinical Trials Network (CTN).  Systematic and standardized collection of organizational and workforce variables may help elucidate site variations and increase the CTN’s understanding of patient outcomes in protocols.  The Smoking-Cessation and Stimulant Treatment (CTN-0046) will be used to assess the influence of organizational and workforce characteristics on trial operations (e.g., rates of participant recruitment and follow-up) and patient outcomes (e.g., reductions in drug use).  This study will build on the analysis of organizational and workforce data in the Baseline Protocol (CTN-0008) and the collection of pre-implementation site data for STAGE-12 (CTN-0031-A-3).  The study’s specific aim is the assessment of associations between site organizational and practitioner variables and site differences in clinical trial outcomes.

RELATED STUDIES
RELATED RESOURCES

snowflake

Publications about CTN-0046-A-1


 

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 2/2011 -- http://ctndisseminationlibrary.org/protocols/ctn0046a1.htm
info@ctndisseminationlibrary.org